Martin Torp Rahbek

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cardiovascular Events

Top Venues

Pharmacoepidemiology and drug safety

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Delvin, Sofie D Egsgaard, Nina Sahlertz Kristiansen, Helene Kildegaard, Lars Christian Lund, Martin Torp Rahbek
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation study. Pharmacoepidemiology and drug safety 33 (3) (2024)
Martin Torp Rahbek, Lars Christian Lund, Nina Sahlertz Kristiansen
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea. Pharmacoepidemiology and drug safety (2023)
Martin Torp Rahbek, Nina Sahlertz Kristiansen, Lars Christian Lund
Trend adjustment of the sequence difference when performing sequence symmetry analyses. Pharmacoepidemiology and drug safety (2023)
Lars Christian Lund, Martin Torp Rahbek, Peter Brown, Niels Obel, Jesper Hallas, Henrik Frederiksen
Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study. European journal of haematology (2023)